• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.

作者信息

Bürki Franck, Badie Kattalin, Bartoli Philippe, Bernard Pascale, Montastruc Jean Louis, Bagheri Haleh

出版信息

Br J Clin Pharmacol. 2008 May;65(5):793-4. doi: 10.1111/j.1365-2125.2008.03119.x. Epub 2008 Feb 15.

DOI:10.1111/j.1365-2125.2008.03119.x
PMID:18279475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2432493/
Abstract
摘要

相似文献

1
Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.与贝伐单抗/阿霉素治疗方案相关的可逆性后部白质脑病综合征
Br J Clin Pharmacol. 2008 May;65(5):793-4. doi: 10.1111/j.1365-2125.2008.03119.x. Epub 2008 Feb 15.
2
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastoma.贝伐单抗诱发的可逆性后部白质脑病综合征及胶质母细胞瘤患者的成功再治疗
J Clin Oncol. 2011 Oct 1;29(28):e739-42. doi: 10.1200/JCO.2011.36.1865. Epub 2011 Sep 6.
3
Reversible posterior leukoencephalopathy syndrome and bevacizumab in breast cancer.
J Clin Oncol. 2012 Sep 10;30(26):e257-9. doi: 10.1200/JCO.2011.38.8942. Epub 2012 May 29.
4
Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab.可逆性后部白质脑病综合征与静脉注射贝伐单抗
Clin Exp Ophthalmol. 2008 Jan-Feb;36(1):94-6. doi: 10.1111/j.1442-9071.2007.01658.x.
5
Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer.贝伐单抗联合化疗诱发的可逆性后部白质脑病综合征在结直肠癌中的情况
World J Gastroenterol. 2014 Jun 7;20(21):6691-7. doi: 10.3748/wjg.v20.i21.6691.
6
Bevacizumab-associated osteonecrosis of the jaw.贝伐单抗相关的颌骨骨坏死
Ann Oncol. 2008 Dec;19(12):2091-2. doi: 10.1093/annonc/mdn653. Epub 2008 Oct 31.
7
Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case.贝伐单抗引起的可逆性后部白质脑病综合征：一例报告。
Dis Colon Rectum. 2008 Sep;51(9):1425-6. doi: 10.1007/s10350-008-9282-8. Epub 2008 May 10.
8
[Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases].
Presse Med. 2019 Oct;48(10):1026-1031. doi: 10.1016/j.lpm.2019.08.019. Epub 2019 Oct 22.
9
Posterior reversible encephalopathy syndrome with bevacizumab.贝伐单抗所致的后部可逆性脑病综合征
Hong Kong Med J. 2011 Feb;17(1):80-1.
10
Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤接受R-CHOP治疗后出现的可逆性后部白质脑病综合征
Ann Hematol. 2010 Feb;89(2):207-8. doi: 10.1007/s00277-009-0783-x. Epub 2009 Jul 7.

引用本文的文献

1
Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review.安罗替尼治疗小细胞肺癌后出现的后部可逆性脑病综合征：一例报告及文献复习
Front Pharmacol. 2023 Feb 6;14:1126235. doi: 10.3389/fphar.2023.1126235. eCollection 2023.
2
Atypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer.贝伐单抗/氟尿嘧啶/亚叶酸钙方案治疗转移性结肠癌后出现的非典型可逆性白质脑病综合征。
Case Rep Oncol Med. 2014;2014:391256. doi: 10.1155/2014/391256. Epub 2014 Oct 21.
3
Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.西地尼布诱发转移性直肠癌患者出现非典型可逆性后部白质脑病综合征（RPLS）。
Invest New Drugs. 2014 Oct;32(5):1036-45. doi: 10.1007/s10637-014-0113-6. Epub 2014 May 23.
4
Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.抗 VEGF 药物引起的后部可逆性脑病综合征。
Target Oncol. 2011 Dec;6(4):253-8. doi: 10.1007/s11523-011-0201-x. Epub 2011 Nov 17.
5
Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.提高医院内药物不良反应报告率：法国米迪-庇里牛斯地区药物警戒网络（PharmacoMIP）为期两年的试点研究结果。
Drug Saf. 2010 May 1;33(5):409-16. doi: 10.2165/11319170-000000000-00000.
6
Looking back: editors' pick of 2008.回首往昔：2008年编辑推荐
Br J Clin Pharmacol. 2009 Jan;67(1):1-4. doi: 10.1111/j.1365-2125.2008.03354.x.

本文引用的文献

1
Reversible posterior leukoencephalopathy syndrome induced by sunitinib.舒尼替尼诱发的可逆性后部白质脑病综合征
J Clin Oncol. 2007 Aug 10;25(23):3559. doi: 10.1200/JCO.2007.12.8710.
2
Hypertension as a predictive factor of Sunitinib activity.高血压作为舒尼替尼活性的预测因素。
Ann Oncol. 2007 Jun;18(6):1117. doi: 10.1093/annonc/mdm184.
3
Reversible posterior leukoencephalopathy syndrome after treatment of diffuse large B-cell lymphoma.
Onkologie. 2007 Mar;30(3):138-40. doi: 10.1159/000098706. Epub 2007 Feb 2.
4
The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review.血管内皮生长因子（VEGF）和血管内皮生长因子受体（VEGFR）靶向血管生成抑制剂的临床毒性概况；综述
Eur J Cancer. 2006 Dec;42(18):3127-39. doi: 10.1016/j.ejca.2006.09.015. Epub 2006 Nov 13.
5
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.贝伐单抗/氟尿嘧啶、亚叶酸钙、伊立替康方案治疗转移性结肠癌后出现的可逆性后部白质脑病综合征
Arch Neurol. 2006 Oct;63(10):1475-8. doi: 10.1001/archneur.63.10.1475.
6
Reversible posterior leukoencephalopathy syndrome and bevacizumab.可逆性后部白质脑病综合征与贝伐单抗
N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2.
7
Reversible posterior leukoencephalopathy syndrome and bevacizumab.可逆性后部白质脑病综合征与贝伐单抗
N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2. doi: 10.1056/NEJMc052954.
8
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.血管内皮生长因子（VEGF）特异性抗体贝伐单抗在人类直肠癌中具有抗血管生成作用的直接证据。
Nat Med. 2004 Feb;10(2):145-7. doi: 10.1038/nm988. Epub 2004 Jan 25.
9
Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤CHOP化疗后可逆性后部白质脑病综合征
Ann Oncol. 2001 Sep;12(9):1327-9. doi: 10.1023/a:1012248800195.